Indaptus Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.55 | -$0.55 | -$0.55 |
| Q2 2024 | 1 | -$0.48 | -$0.48 | -$0.48 |
| Q3 2024 | 1 | -$0.50 | -$0.50 | -$0.50 |
| Q1 2025 | 1 | -$0.41 | -$0.41 | -$0.41 |
| Q2 2025 | 1 | -$0.36 | -$0.36 | -$0.36 |
| Q3 2025 | 1 | -$0.31 | -$0.31 | -$0.31 |
| Q4 2025 | 1 | -$0.32 | -$0.32 | -$0.32 |
Indaptus Therapeutics, Inc. Earnings Date And Information
Indaptus Therapeutics, Inc. last posted its earnings results on Monday, August 12th, 2024. The company reported $-0.47 earnings per share for the quarter, topping analysts' consensus estimates of $-0.54 by $0.07. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Indaptus Therapeutics, Inc. has generated $-2 earnings per share over the last year ($-1.84 diluted earnings per share) and currently has a price-to-earnings ratio of -0.63. Indaptus Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 6th, 2024 based on prior year's report dates.
Indaptus Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/12/2024 | Q2 2024 | -$0.54 | -$0.47 | 0.07 | $0 | $0 |
| 05/08/2024 | Q1 2024 | -$0.57 | -$0.45 | 0.12 | $0 | |
| 03/13/2024 | Q4 2023 | -$0.54 | -$0.48 | 0.06 | $1,928 | |
| 11/06/2023 | Q3 2023 | -$0.55 | -$0.47 | 0.08 | $0 | |
| 08/14/2023 | Q2 2023 | -$0.58 | -$0.39 | 0.19 | $0 | |
| 05/11/2023 | Q1 2023 | -$0.59 | -$0.48 | 0.11 | $0 | |
| 03/17/2023 | Q4 2022 | -$0.52 | -$0.39 | 0.13 | $0 | |
| 11/10/2022 | Q3 2022 | -$0.47 | -$0.41 | 0.06 | $0 | |
| 08/08/2022 | Q2 2022 | -$0.43 | -$0.46 | -0.03 | $0 | |
| 05/12/2022 | Q1 2022 | -$0.39 | -$0.40 | -0.01 | $0 | |
| 03/21/2022 | Q4 2021 | -$0.90 | -$0.00 | 0.9 | $0 | |
| 11/15/2021 | Q3 2021 | -$0.55 | -$0.81 | -0.26 | $25.00 M | $0 |
| 08/16/2021 | Q2 2021 | -$2.56 | -$1.37 | 1.19 | $0 | |
| 06/28/2021 | Q1 2021 | -$0.11 | $0 | |||
| 12/31/2020 | Q4 2020 | -$0.14 | $0 | |||
| 09/29/2020 | Q3 2020 | -$0.29 | $0 | |||
| 06/29/2020 | Q2 2020 | -$0.55 | $0 | |||
| 03/30/2020 | Q1 2020 | -$0.76 | $0 |
Indaptus Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Indaptus Therapeutics, Inc.'s earnings date?
Indaptus Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 6th, 2024 based off last year's report dates.
-
Did Indaptus Therapeutics, Inc. beat their earnings estimates last quarter?
In the previous quarter, Indaptus Therapeutics, Inc. (:INDP) reported $-0.47 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.54 by $0.07.
-
How can I listen to Indaptus Therapeutics, Inc.'s earnings conference call?
The conference call for Indaptus Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Indaptus Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Indaptus Therapeutics, Inc.'s latest earnings report can be read online.
-
How much profit does Indaptus Therapeutics, Inc. generate each year?
Indaptus Therapeutics, Inc. (:INDP) has a recorded net income of $0. Indaptus Therapeutics, Inc. has generated $-1.84 earnings per share over the last four quarters.
-
What is Indaptus Therapeutics, Inc.'s price-to-earnings ratio?
Indaptus Therapeutics, Inc. (:INDP) has a price-to-earnings ratio of -0.63 and price/earnings-to-growth ratio is 0.14.
